(Q33967497)

English

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

Clelia Madeddu

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Giulia Gramignano

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Paraskevas Kotsonis

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Francesco Paribello

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Antonio Macciò

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

4 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Oncology Letters

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1279-1282

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Tamoxifen and ovarian function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

What is the current status of ovarian suppression/ablation in women with premenopausal early-stage breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Adjuvant therapy for very young women with breast cancer: need for tailored treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

The effects of tamoxifen therapy on the endometrium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Ovarian cysts in women receiving tamoxifen for breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

5 July 2018

Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

29 October 2018

Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

29 October 2018

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

29 October 2018

Successful management of an ovarian enlargement resembling ovarian hyperstimulation in a premenopausal breast cancer patient receiving tamoxifen with cotreatment of GnRH-agonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114603

29 October 2018

Adjuvant endocrine therapy for premenopausal women with early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACOG committee opinion. No. 336: Tamoxifen and uterine cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic approach to ovarian cysts in tamoxifen-treated women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25120706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OL.2014.2319

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33967497&oldid=1962223041"